In 970 patients with branch atheromatous disease-related ischaemic stroke, IV tirofiban plus aspirin did not significantly reduce early deterioration or 90-day stroke vs placebo plus aspirin (17.1% vs 19.6%; HR 0.88, 95% CI 0.65-1.19); bleeding was rare.
RCTn = 970
Wang et al. Tirofiban for Branch Atheromatous Disease-Related Stroke: The STRATEGY Randomized Clinical Trial